HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful treatment of mixed-type autoimmune hemolytic anemia with rituximab in a child following liver transplantation.

Abstract
Development of a severe form of mixed-type AIHA after orthotopic liver transplantation is a rare, but a life-threatening event. We report a case of mixed-type AIHA that developed in a child after hepatocyte and living-related orthotopic liver transplantation for factor VII deficiency.
AuthorsWolfram Haller, Jonathan Hind, Sue Height, Ragai Mitry, Anil Dhawan
JournalPediatric transplantation (Pediatr Transplant) Vol. 14 Issue 3 Pg. E20-5 (May 2010) ISSN: 1399-3046 [Electronic] Denmark
PMID19254271 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Immunologic Factors
  • Rituximab
Topics
  • Anemia, Hemolytic, Autoimmune (drug therapy)
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Murine-Derived
  • Humans
  • Immunologic Factors (therapeutic use)
  • Infant
  • Liver Transplantation
  • Male
  • Postoperative Complications (drug therapy)
  • Rituximab

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: